Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Conjunctival mantle cell lymphoma-a therapeutic challenge].
Trouvain AM, Bocqué C, Müller LJ, Heinrich C, Bewarder M, Pérez Guerra N, Szurman G, Becker SL, Rickmann A. Trouvain AM, et al. Among authors: szurman g. Ophthalmologie. 2022 Aug;119(8):837-840. doi: 10.1007/s00347-021-01462-w. Epub 2021 Jul 28. Ophthalmologie. 2022. PMID: 34319474 German. No abstract available.
Long-term results after artificial iris implantation in patients with aniridia.
Rickmann A, Szurman P, Januschowski K, Waizel M, Spitzer MS, Boden KT, Szurman GB. Rickmann A, et al. Among authors: szurman gb. Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1419-24. doi: 10.1007/s00417-016-3292-3. Epub 2016 Feb 19. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 26892143
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.
Januschowski K, Feltgen N, Pielen A, Spitzer B, Rehak M, Spital G, Dimopoulos S; Bevacizumab Study Group Venous Occlusion; Meyer CH, Szurman GB. Januschowski K, et al. Among authors: szurman gb. Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):457-462. doi: 10.1007/s00417-016-3471-2. Epub 2016 Sep 8. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 27632214
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre study.
Szurman GB, Januschowski K, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Dimopoulos S; Bevacizumab Study Group Venous Occlusion; Meyer CH. Szurman GB, et al. Acta Ophthalmol. 2017 May;95(3):e245-e246. doi: 10.1111/aos.12976. Epub 2016 Feb 1. Acta Ophthalmol. 2017. PMID: 26833721 Free article. No abstract available.
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.
Szurman GB, Meyer CH, Feltgen N, Pielen A, Spitzer B, Rehak M, Spital G, Dimopoulos S, Szurman P; Bevacizumab Study Group Venous Occlusion; Januschowski K. Szurman GB, et al. Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):1045-1046. doi: 10.1007/s00417-017-3618-9. Epub 2017 Feb 21. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28224287 No abstract available.
12 results